Martin Torp Rahbek

7PUBLICATIONS
7CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsEpidemiological modellingHaematological tumoursBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 20, 2025
Screening real-world data for evidence of unsuspected drug benefits: An application of the sequence symmetry analysis.

Martin Torp Rahbek, Lars Christian Lund, Jesper Hallas

|May 20, 2025
Obtaining Valid Compatibility Intervals for Sequence Symmetry Analyses Utilizing Active Comparators: A Simulation Study.

Martin Torp Rahbek, Jesper Hallas, Lars Christian Lund

|Mar 07, 2024
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation study.

Thomas Delvin, Sofie Egsgaard, Jesper Hallas

|Sep 23, 2023
Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.

Lars Christian Lund, Martin Torp Rahbek, Peter Brown

|Aug 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea.

Martin Torp Rahbek, Lars Christian Lund, Jesper Hallas

Pageof 2

Frequent Collaborators

6 joint publications

Lars Christian Lund

4 joint publications

Jesper Hallas

1 joint publications

Henrik Frederiksen

1 joint publications

Thomas Delvin